Oct 19, 2011 09:00 EDT “Global customer proximity is Attana’s next step towards assuring that our customers receive highest quality support and service through established distributors,” commented Teodor Aastrup, CEO and founder of Attana.
Press Release
Attana AB and Layerlab AB sign global distribution agreement
Sep 20, 2011 09:00 EDT
Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.
memLAYER™, one of Layerlab’s core products, is a chemistry kit that provides biosensor users with a unique approach of immobilizing biological membranes to biosensor surfaces. This enables easier analysis of membrane protein functionality, saving both time and money in the process of drug development.
“Attana is continually striving for collaborations that lead to innovative and efficient applications for our customers. Layerlab’s immobilization technology compliments Attana’s biosensors and offers our customers easier and faster applications for studies of molecular interactions.” says Teodor Aastrup, CEO and founder of Attana.
”Attana is a considerable actor on the biosensor market and we are pleased that memLAYER™ will now be utilized on Attana’s QCM biosensors. The collaboration will lead to increased areas of use for memLAYER™ and supports our strategi to globally increase our local presence on the biosnesor market.” says Torbjörn Pettersson CEO Layerlab AB.
Attached Files
Categorization
- Tags:
- attana cell 200,
- membrane,
- attana,
- qcm,
- layerlab,
- memlayer,
- biosensors
Related press releases
Related images
Jun 02, 2010 09:18 EDT Cell and biochemical assays Analyte/ligand types: - Adherent cells - Suspension cells - Fixed and non-fixed cells - Crude samples - Proteins, antibodies, carbohydrates - Viruses, bacteria Applications: - Kinetics on cells - Cell capturing - Detailed kinetics - Concentration determination - Competition assay - Epitope mapping - Off-rate selection - Aggregation characterization
Related videos
Mar 02, 2011 03:00 EST
Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.
Length 5:00
Jan 14, 2011 03:00 EST
Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, the Attana Cell 200 minimizes costs and increases success during clinical trials. (produced by TTV AB)
Length 1:24
Add commentThe comment was saved
Prior to publication, it must be approved by Attana AB.